Status:
COMPLETED
Soluble CD95 Ligand Role in the Pathophysiology of Non-infectious Active Uveitis
Lead Sponsor:
University Hospital, Bordeaux
Conditions:
Non-Infectious Active Uveitis
Eligibility:
All Genders
18+ years
Brief Summary
The study aims at defining the role of soluble CD95 Ligand in the physiopathology of the non-infectious uveitis. Soluble CD95 Ligand might have a prognostic interest as well as potential for the disco...
Detailed Description
Non-Infectious active uveitis is a severe inflammatory ocular disease which can expose to the blindness. Actually, the knowledge of the physiopathology of uveitis stay poorly. CD95 Ligand (CD95-L) bel...
Eligibility Criteria
Inclusion
- Diagnosis of non-infectious uveitis according to the SUN (Standardization of the Uveitis Nomenclature) working Group;
- Age ≥ 18 years;
- being affiliated to health insurance,
- willing to participate.
Exclusion
- Pregnant or breastfeeding women,
- patient under legal protection measure ,
- poor understanding of the French language
Key Trial Info
Start Date :
November 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 10 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04354909
Start Date
November 17 2020
End Date
March 10 2023
Last Update
May 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Bordeaux
Bordeaux, France